COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 358.2 | 3 | 0071-0376 | 407.77 | 376.33 | 403 | 74.43 | 0.914 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 370.7 | 3 | 0072-0383 | 548.09 | 383.47 | 271 | 61.36 | 0.905 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 293.4 | 3 | 0073-0386 | 55.28 | 386.66 | 263 | 61.94 | 0.861 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 220.6 | 3 | 0074-0389 | 468.20 | 389.24 | 355 | 71.01 | 0.885 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 238.0 | 3 | 0075-0397 | 757.28 | 397.31 | 318 | 66.43 | 0.906 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 210.2 | 3 | 0076-0407 | 593.49 | 407.72 | 303 | 65.60 | 0.885 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.9 | 3 | 0077-0411 | 77.32 | 411.36 | 338 | 74.53 | 0.765 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 444.7 | 3 | 0078-0415 | 667.54 | 414.74 | 411 | 79.26 | 0.822 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.2 | 3 | 0079-0419 | 610.37 | 419.36 | 314 | 70.53 | 0.793 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 237.1 | 3 | 0080-0418 | 171.29 | 417.35 | 336 | 70.67 | 0.845 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 250.6 | 3 | 0081-0420 | 436.94 | 420.27 | 281 | 66.43 | 0.800 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 314.7 | 3 | 0082-0432 | 899.32 | 432.10 | 265 | 65.60 | 0.774 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.1 | 3 | 0083-0438 | 699.89 | 438.70 | 296 | 63.11 | 0.934 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 195.8 | 3 | 0084-0444 | 43.31 | 444.10 | 338 | 70.77 | 0.848 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 306.5 | 3 | 0085-0456 | 495.79 | 456.18 | 406 | 77.50 | 0.849 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 247.6 | 3 | 0086-0460 | 909.25 | 460.74 | 187 | 53.94 | 0.808 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 232.9 | 3 | 0087-0465 | 185.70 | 465.70 | 314 | 67.94 | 0.855 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 217.2 | 3 | 0088-0474 | 639.22 | 474.30 | 345 | 69.36 | 0.901 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.2 | 3 | 0089-0477 | 108.91 | 477.06 | 326 | 70.43 | 0.826 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 236.3 | 3 | 0090-0483 | 496.72 | 482.98 | 270 | 66.43 | 0.769 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 209.5 | 3 | 0091-0489 | 136.73 | 489.56 | 356 | 70.18 | 0.908 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 311.5 | 3 | 0092-0490 | 780.75 | 490.99 | 267 | 61.36 | 0.891 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 213.0 | 3 | 0093-0495 | 49.45 | 494.62 | 325 | 71.01 | 0.810 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 238.9 | 3 | 0094-0500 | 347.91 | 499.38 | 295 | 64.18 | 0.900 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 240.8 | 3 | 0095-0505 | 919.44 | 505.45 | 336 | 70.18 | 0.857 |